As of Oct 21
| +0.0198 / +2.87%|
The 3 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 1.50. The median estimate represents a +604.42% increase from the last price of 0.71.
The current consensus among 3 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.